Literature DB >> 1797162

Mechanism and clinical significance of soluble hepatic cell-surface receptors.

Y Kohgo1, H Kondo, Y Mogi, Y Niitsu.   

Abstract

Transferrin receptors take up transferrin-iron complexes into hepatic cells. Although the receptor is not highly expressed in normal liver cells, malignant transformation of the cells increases its expression. As part of the expressed receptors are released into blood, a significant increase of serum receptors are observed in cases of hepatoma. Therefore, measurement of transferrin receptors in blood from patients with hepatoma may be useful for estimating the tumor burden and determinating therapeutic effects. Asialoglycoprotein receptors are expressed strongly in normal liver cells, whereas the expression is decreased in various chronic liver diseases and hepatoma. Although the active shedding of the receptors clearly occurs in vitro, as does that of the transferrin receptor, determination of the significance of these shed receptors in blood will require further studies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1797162

Source DB:  PubMed          Journal:  Targeted Diagn Ther        ISSN: 1046-1906


  3 in total

1.  Preparation and identification of scFv and bsFv against transferrin receptor.

Authors:  Jing Liu; Daiwen Xiao; Xiaoou Zhou; Xue Wen; Hong Dai; Zhihua Wang; Xin Shen; Wei Dai; Daofeng Yang; Guanxin Shen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-12-24

2.  Soluble and cell-associated transferrin receptor in lung cancer.

Authors:  A Dowlati; M Loo; T Bury; G Fillet; Y Beguin
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Generation and functional characterization of the anti-transferrin receptor single-chain antibody-GAL4 (TfRscFv-GAL4) fusion protein.

Authors:  Qing Ye; Heyu Hu; Zhihua Wang; Tong Lu; Zhiquan Hu; Xing Zeng; Shu Zhang; Jing Liu; Ping Lei; Cong-Yi Wang; Zhangqun Ye; Guanxin Shen
Journal:  BMC Biotechnol       Date:  2012-11-28       Impact factor: 2.563

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.